Waning but persistent humoral response 6 months after the third dose of the mRNA BNT162b2 vaccine in hemodialysis and peritoneal dialysis patients

J Nephrol. 2022 Apr;35(3):783-785. doi: 10.1007/s40620-022-01276-2. Epub 2022 Feb 22.

¹ Department of Nephrology, Centre Hospitalier Sud-Francilien, Corbeil-Essonnes, France. [email protected].
² Department of Microbiology, Centre Hospitalier Sud-Francilien, Corbeil-Essonnes, France.
³ Department of Nephrology, Centre Hospitalier Sud-Francilien, Corbeil-Essonnes, France.
⁴ Department of Nephrology, Centre Hospitalier Sud-Francilien, Corbeil-Essonnes, France. [email protected].
⁵ INSERM UMRS 1018, Clinical Epidemiology Unit, Centre for Research in Epidemiology and Population Health, Paris-Saclay University, Villejuif, France. [email protected].

No abstract available

Keywords: COVID-19; Hemodialysis; Humoral response; Peritoneal dialysis; SARS-CoV-2; mRNA BNT162b2 vaccine.

Publication types